G. Kuppuswamy Naidu Memorial (GKNM) Hospital inaugurated ROSCON 2026, a Robotic Oncosurgery Conference, today at the hospital.
The three-day event, which began on 20th March 2026, will continue until 22nd March. It is an initiative of the Valavadi Narayanaswamy Cancer Centre (VNCC), the hospital’s oncology department.
Dr. Ragupathy Veluswamy, Chief Executive Officer of the hospital, was the chief guest and delivered the presidential address. Dr. Somasekhar, Chairman MAB, Aster DM Healthcare GCC & India Global Director, Aster Oncology, Bengaluru, served as the guest of honour and spoke on “Evolution of Robotic Surgery in Oncology – An Indian Perspective.”
Dr. Arulraj, Organising Co-Chairman and Consultant Surgical Oncologist, Robotic & HIPEC Surgeon, delivered the welcome address. Dr. Sivanesan, Chairman of the Department of Oncology and HOD Medical Oncology, gave the felicitation address. Dr. Subbiah Shanmugam, President of the Tamil Nadu Association of Surgical Oncology, delivered a special address.
Dr. Praveen Ravishankaran, Organising Secretary of ROSCON 2026 and Consultant, Surgical Oncology (Lap, Robotic, and HIPEC Surgeon), proposed the vote of thanks. Dr. Mohan Raj, Chief of Surgical Oncology, was also present.
The conference was attended by leading national and international experts in robotic cancer surgery, who graced the occasion with their presence and insights.
ROSCON is a premier academic initiative dedicated to advancing robotic-assisted surgical techniques in oncology. It aims to bridge the gap between technology and clinical practice by providing a robust platform for education, innovation, and collaboration among surgeons and healthcare professionals.
The conference serves as a dynamic platform for knowledge exchange, skill enhancement, and the advancement of cutting-edge oncological care.
It has been thoughtfully curated to showcase the latest innovations and evolving techniques in robotic-assisted cancer surgery. With a strong emphasis on precision, minimally invasive approaches, and improved patient outcomes, the conference highlights the transformative impact of robotics in modern oncological practice.
A major highlight of the conference is the live surgical workshops, where complex oncological procedures—including robotic esophagectomy and advanced thoracic and gastrointestinal surgeries—are being demonstrated in real time by expert surgeons. These sessions provide invaluable insights into surgical planning, intraoperative strategies, and postoperative care, enabling delegates to directly observe and learn from leaders in the field.
The conference also features hands-on training sessions, particularly tailored for gynecologists and surgeons seeking practical exposure to robotic platforms such as the Da Vinci Xi system. These sessions offer participants a unique opportunity to experience the precision, dexterity, and ergonomic advantages of robotic-assisted surgery under expert supervision.
In addition to the scientific program, ROSCON 2026 fosters academic collaboration through panel discussions, keynote lectures, and interactive sessions spanning a wide range of oncological specialities—including thoracic, gastrointestinal, gynaecological, and urological malignancies.
The event has attracted a diverse group of delegates, including surgeons, oncologists, trainees, and healthcare professionals from across the country.
Speaking on the occasion, the organising committee emphasised that ROSCON aims not only to disseminate advanced surgical knowledge but also to build a strong community of robotic surgeons committed to improving access to high-quality cancer care across India.
The enthusiastic participation and academic rigour witnessed at ROSCON 2026 reflect the rapidly growing adoption of robotic surgery in oncology and its potential to redefine standards of care.
The conference is expected to catalyse future collaborations, training initiatives, and innovations in minimally invasive cancer treatment.
